ABOUT
THE REVIEW NETWORK | |
 
| Spotlight:
Biotechnology and the Law
Written
to help lawyers faced with the challenge of identifying the legal issues surrounding
the biotech business, this book provides thorough, yet accessible, overviews of
biotech subspecialties with an eye to practical application.
Order
online |
| Biotechnology
has become one of the most heavily-invested industries in the United States, with
U.S. health-care biotech revenues increasing from $8 billion in 1992 to $50.7
billion in 2005 -- and it's growing larger: In the third quarter of 2007 alone,
the life sciences sector, combining biotechnology and medical devices, reported
venture capital investments of $1.9 billion going into 175 deals, with biotech
having $1.1 billion going into 99 deals, while medical devices had $825 million
going into 76 deals.
Realizing the tremendous impact of this industry
for the 21st century, regions across the country have exponentially increased
the number of biotechnology companies, academic centers, state and local associations
and related enterprises within their areas. Specifically, three regions are acknowledged
as world leaders in the biotechnology industry: the San Francisco Bay Area, cities
and states within the New England region and the state of North Carolina. Due
to these regions' escalating amount of information, transactions, groundbreaking
discoveries and more, the Biotech Review Network was established to help provide
a free daily review of the news regarding biotech-related organizations within
each of these areas.
about
the newsletters.....about the categories.....more
about us
|
 |  |  | With
the world's largest concentration of bioscience companies, the San Francisco Bay
Area is widely considered to be the country's biotech capital. World-changing
developments and deals happen daily in towns and regions such as Silicon Valley,
Genentech-centered South San Francisco, Marin County, Berkeley, and more, and
BayBiotech Review is there to present it all.
Go
to BayBiotech Review and subscribe FREE!
back
to top
| The
cities and states within the New England area are making extraordinary advances
in the global biotechnology industry. NEBiotech Review relays the academic
research, burgeoning business and important initiatives such as Massachusetts
Biotech 2010 that primes the New England area for even more growth, especially
in development, commercialization and manufacturing.
NEBiotech
Review coming in Summer 2009 | Led
by Research Triangle Park, the world's largest research park, North Carolina's
biotechnology industry has been buoyed by phenomenal local resources and significant
economic advantages. NCBiotech Review covers three main biomedical "hubs"
(which include Charlotte and the Triad area), informing readers daily about the
latest news regarding the state's biotech industry.
NCBiotech
Review coming in Summer 2009
|
| | No
industry in the world is so reliant on news regarding study results, patent awards,
startups and other discoveries than biotechnology and life sciences. Thousands
of press releases are sent each day detailing biotech advances, clinical data,
and more, and the Biotech Review Network organizes these important developments
daily in each region's "Press Releases" section. | From
simple partnerships to billion-dollar mergers, the biotechnology industry sees
deals, investments, and financing occurring every day worldwide. Almost every
company located in the Biotech Review Network regions feels the impact of these
transactions, and each region's newsletter presents all information relevant to
its readers. | | | | | Conferences.
Seminars. Medical society meetings. Training courses. Networking opportunities.
As biotech grows, so do the events and meetings regarding developments and issues
in the industry. BRN newsletters posts the upcoming events in each issue and more
information regarding additional future events (and past events) is available
on each region's site. | The
biotechnology industry -- growing larger in revenue, progress and controversy
-- has caused the media contigent covering it to grow as well. The Biotech Review
Network scours local/national media, niche science titles, blogs, international
reports, academic publications and much more, in order to provide links to relevant
media coverage. | | |
|